Skip to content
10-Q

Quarterly Report

Xenon Pharmaceuticals Inc. XENE

0000950170-25-106599

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 7, 2025 77.11M sh
Shares Diluted Q2 2025 · Jun 30, 2025 78.95M sh
Shares Diluted Q2 2025 · Jun 30, 2025 78.82M sh
Shares Diluted Q2 2025 · Jun 30, 2024 77.67M sh
Shares Diluted Q2 2025 · Jun 30, 2024 77.63M sh
Capex Q2 2025 · Jun 30, 2025 $200K
Capex Q2 2025 · Jun 30, 2024 $1.7M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$125.89M
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 −$77.34M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $135.38M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $142.71M
Stockholders Equity Q2 2025 · Jun 30, 2025 $633.98M
Stockholders Equity Q2 2025 · Mar 31, 2025 $703.96M
Stockholders Equity Q2 2025 · Dec 31, 2024 $754.9M
Stockholders Equity Q2 2025 · Jun 30, 2024 $844.05M
Stockholders Equity Q2 2025 · Mar 31, 2024 $887.7M
Stockholders Equity Q2 2025 · Dec 31, 2023 $927.92M
Current Liabilities Q2 2025 · Jun 30, 2025 $33.05M
Current Liabilities Q2 2025 · Dec 31, 2024 $35.59M
Total Liabilities Q2 2025 · Jun 30, 2025 $40.3M
Total Liabilities Q2 2025 · Dec 31, 2024 $43.24M
Current Assets Q2 2025 · Jun 30, 2025 $500.25M
Current Assets Q2 2025 · Dec 31, 2024 $635.26M
Total Assets Q2 2025 · Jun 30, 2025 $674.28M
Total Assets Q2 2025 · Dec 31, 2024 $798.14M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.07
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.90
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.75
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.36
Eps Basic Q2 2025 · Jun 30, 2025 −$1.07
Eps Basic Q2 2025 · Jun 30, 2025 −$1.90
Eps Basic Q2 2025 · Jun 30, 2024 −$0.75
Eps Basic Q2 2025 · Jun 30, 2024 −$1.36
Sga Expense Q2 2025 · Jun 30, 2025 $19.24M
Sga Expense Q2 2025 · Jun 30, 2025 $38.28M
Sga Expense Q2 2025 · Jun 30, 2024 $19.4M
Sga Expense Q2 2025 · Jun 30, 2024 $34.19M
Rd Expense Q2 2025 · Jun 30, 2025 $74.99M
Rd Expense Q2 2025 · Jun 30, 2025 $136.19M
Rd Expense Q2 2025 · Jun 30, 2024 $49.7M
Rd Expense Q2 2025 · Jun 30, 2024 $93.95M
Net Income Q2 2025 · Jun 30, 2025 −$84.71M
Net Income Q2 2025 · Jun 30, 2025 −$149.75M
Net Income Q2 2025 · Mar 31, 2025 −$65.05M
Net Income Q2 2025 · Jun 30, 2024 −$57.92M
Net Income Q2 2025 · Jun 30, 2024 −$105.86M
Net Income Q2 2025 · Mar 31, 2024 −$47.93M
Operating Income Q2 2025 · Jun 30, 2025 −$94.23M
Operating Income Q2 2025 · Jun 30, 2025 −$166.97M
Operating Income Q2 2025 · Jun 30, 2024 −$69.1M
Operating Income Q2 2025 · Jun 30, 2024 −$128.15M